Results -An increasing number of respiratory isolates with Pseudomonas aeruginosa was found over this time period. Eighteen of the 224 patients were identified in whom P aeruginosa was recovered on at least one occasion. These patients were more likely to have a history of smoking and prior PCP than those in whom Pseudomonas was not recovered. Mean CD4 counts were also significantly lower in these patients. Conclusions -Pseudomonas aeruginosa may be recovered from a substantial number of respiratory isolates from HIV positive patients suspected ofhaving PCP. The prevalence of this phenomenon may be increasing.
Pseudomonas aeruginosa is a respiratory pathogen found most commonly in patients admitted to hospital, those undergoing prolonged mechanical ventilation, patients with Patients were considered to be smokers if they were currently smoking or, despite having quit, had a significant smoking history (>10 pack years) and had abstained for less than two years. Radiographs were classified as "focal", "diffuse", or "normal" based on the final radiographic reading by staff radiologists. Radiographic findings categorised as "focal" included focal infiltrates, effusions, masses, and cavities. CD4 counts were recorded at the time of presentation for each respiratory symptom episode when available, and otherwise were considered for analysis only if they had been 
Results
Between 1989 and 1992 224 HIV positive patients presented with 324 episodes of respiratory complaints prompting an evaluation (sputum induction and/or bronchoalveolar lavage) for PCP. Eighteen patients were identified in whom P aeruginosa was recovered on at least one evaluation. The clinical characteristics of the -PsA group (n = 206) and the + PsA group (n = 18) are described in table 1. In the + PsA group patients were more likely to be current smokers and to have had prior episodes of PCP than the -PsA group.
The total number of episodes of respiratory complaints prompting sputum induction and/ or bronchoalveolar lavage in the two patient groups is compared in table 2. Among the 18 patients from whom P aeruginosa was recovered at least once, there were 32 episodes prompting either sputum induction and/or bronchoalveolar lavage for suspected PCP. P aeruginosa was recovered in 22 of these 32 episodes, and was the only pathogen recovered in 14 of the episodes. Eight patients had more than one respiratory episode during this time period; one patient had four episodes. Once P aeruginosa had been recovered in a respiratory specimen any subsequent sputum induction and/or bronchoalveolar lavage specimens were found to be positive for this organism. Recovery of Pneumocystis carinii in the two groups was similar.
Chest radiographs were available for 322 episodes of respiratory symptoms (table 3). All patterns were seen in patients from whom P aeruginosa was recovered and there was no significant difference in findings between the two groups. Focal findings consisted of upper lobe cavities in three patients, upper lobe infiltrates in two patients, and an upper lobe nodule in one patient.
Seventeen of the 18 patients with recovery ofPseudomonas in either bronchoalveolar lavage or sputum induction specimens were inpatients at the time of first recovery of the organism; however, most (16/18) had short hospital stays Doyle, Doherty, Zimmerman (less than five days) prior to the recovery of Pseudomonas. In general, the Pseudomonas organisms recovered from these patients were sensitive to first line antipseudomonal therapy (e.g. piperacillin, gentamicin). Only three of the 18 patients received antipseudomonal therapy as defined by 10-14 days of an antipseudomonal antibiotic. Two ofthe 18 patients were on multiple antibiotics for documented Mycobacterium avium infection and 14 were receiving PCP prophylaxis. Detailed follow up was available for 16 of the 18 patients in the + PsA group and for 184 of the 206 patients in the -PsA group. The mean (SD) time to death for the 16 patients in the + PsA group was 6-0 (7 5) months compared with 119 (11-5) months in the -PsA group, a difference which was significant (p<0.05).
The data presented in the figure show that from 1989 to 1992 there was an increase in the number ofpatients from whom Paeruginosa was recovered. Baron and Hollander, 10 of the 16 patients in our study died within six months of recovery of the organism from a respiratory specimen. This indicates either the pathogenicity of P aeruginosa, or the propensity of the organism to colonise the respiratory tracts of patients with late stage HIV disease, or both.
The recovery ofPaeruginosa from respiratory specimens from symptomatic HIV positive patients increased from 3% in 1989 to 17% in 1992. The clinical presentation of these patients was typified by fever, dyspnoea, and radiographic evidence of pulmonary infiltrates -the classic presentation of patients with PCP. In 14 of the 22 episodes, however, P aeruginosa was the only pathogenic organism recovered. These results emphasise the need for definitive diagnosis of pulmonary infiltrates in HIV positive patients. However, a case-control study is needed to determine the risk factors for acquisition ofP aeruginosa in this patient population. Such a study would answer more definitively some of the questions raised by our observations, specifically the role of environmental exposures, prophylactic antibiotics, comorbid diseases, and number of hospital admissions in the acquisition ofPseudomonas, and its overall impact on the morbidity and mortality of HIV positive patients.
